Seattle Children’s Hospital in Seattle, Washington, US, has deployed VentriPoint Diagnostics’ VMS heart analysis system.
The hospital will use the device to study children with congenital and acquired heart diseases.
The device also helps in studying anaemic children with dilated hearts and who receive multiple blood donations.
Seattle Children’s Hospital echocardiography laboratory interim director and University of Washington School of Medicine assistant professor of paediatrics and adjunct assistant professor of radiology Brian Soriano said the hospital’s echocardiography laboratory will work with VentriPoint to evaluate the performance of VMS.
"In the clinical world, there is a need for objective, precise, and accurate assessments of right ventricular function. Traditionally, subjective measures of function have been used," Soriano added.
"When compared to traditional echocardiographic methods, VMS has the potential to offer more accurate and precise ventricular volumes in a time-efficient manner."
VentriPoint has designed the VMS diagnostic tool to measure right ventricle heart function and has updated it to interface with newer digital ultrasound machines and to export VMS studies to the standard hospital archiving database.
The database will then facilitate access to the ultrasound images and VMS results from anywhere in the hospital.
The VMS is approved for investigational use in the US, while it is permitted for clinical use in Canada and Europe.
VentriPoint CEO Dr George Adams said the VMS installation will allow the company to view its use in a paediatric clinical setting in the US.
"In addition, we will be doing research to look at expanding the VMS applications to include patients with acquired heart conditions," Dr Adams added.
Congenital heart disease in children is the first application in a set of applications for all major heart diseases such as pulmonary hypertension, cardiovascular disease and heart failure, according to VentriPoint Diagnostics.